Placenta derived Mesenchymal Stem Cells transplantation in Type 1 diabetes: preliminary report of phase 1 clinical trial

DiscussionThis preliminary report of our phase I clinical trial demonstrated the short term safety of PLMSCs transplantation in juvenile T1DM. To prove the long term safety and probable efficacy of this treatment more investigations are needed.Trial registrationIranian Registry of Clinical Trials: IRCT20171021036903N2

Source: Journal of Diabetes and Metabolic Disorders - July 9, 2021 Category: Endocrinology Source Type: research